Rocuronium Injection, Solution
Product Images NDC 76045-220

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 76045-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Roc09 0007 01)

Chemical structure of rocuronium bromide showing its steroid-based molecular framework with various functional groups, including an epoxide, a quaternary ammonium group, and a bromide ion. The diagram illustrates the compound's detailed atomic bonding and arrangement.*

FDA Label Image

Figure 1 (Roc09 0007 02)

A scatter plot depicting data points of minutes on the vertical axis against dosage in mg/kg on the horizontal axis for three age groups: 18-64 years, 65 years and older, and 1-12 years. The plot shows distribution and variability of response times by dosage and age for Rocuronium Bromide intravenous injection.*

FDA Label Image

Figure 2 (Roc09 0007 03)

A box-and-whisker plot comparing a variable measured in minutes across different age groups and dosage levels in mg/kg. The age groups include 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. The x-axis shows dose categories, and the y-axis shows time in minutes.*

FDA Label Image

Figure 3 (Roc09 0007 04)

A line graph depicting the relationship between dose number and time in minutes for Rocuronium at dosages of 0.1 mg/kg and 0.15 mg/kg. It shows time values on the y-axis and dose number on the x-axis, comparing two dosage groups with sample sizes labeled N=29 and N=13 respectively.*

FDA Label Image

Figure 1 (Roc09 0007 05)

Illustration of a prefilled syringe labeled with parts including plunger rod, syringe barrel, drug color band, label, syringe tip cap, and tamper evident cap. The diagram visually identifies components of the syringe used for drug administration.*

FDA Label Image

Figure 2 (Roc09 0007 06)

An instructional illustration showing how to open a syringe with tamper-evident (TE) components. The left panel shows twisting to break TE frangibles, and the right panel shows removal of the TE cap from the syringe tip.*

FDA Label Image

Figure 3 (Roc09 0007 07)

An instructional diagram showing a person removing a cap from a syringe or vial. One hand holds the syringe or vial while the other hand twists and pulls off the cap, indicated by an arrow and rotation symbol.*

FDA Label Image

Fresenius Kabi Logo (Roc09 0007 08)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Rocuronium Bromide Injection label showing a 50 mg/5 mL (10 mg/mL) solution in a 5 mL single-dose prefilled syringe for intravenous use. The label includes storage instructions to keep at 20°C to 25°C and warnings about its paralyzing effects. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) in prefilled syringes. The carton label states the injection is for intravenous use only and warns that it is a paralyzing agent causing respiratory arrest, requiring facilities for artificial respiration. The package contains 10 single-dose 5 mL prefilled syringes. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Rocuronium Bromide Injection Syringe Label)

Label for Rocuronium Bromide Injection, solution for intravenous use, at a concentration of 10 mg/mL with a total volume of 5 mL (50 mg). The single-dose prefilled syringe is manufactured by Fresenius Kabi, labeled with storage instructions and a warning about its paralyzing effects. The label includes a barcode and an NDC number 76045-221-05.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Rocuronium Bromide Injection Carton Panel)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous solution. The label states it is for intravenous use only, with warnings about the drug being a paralyzing agent that causes respiratory arrest. Packaging is for 10 x 5 mL single-dose prefilled syringes by Fresenius Kabi USA, LLC. NDC 76045-221-50 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.